Posts

Single Midlife PSA Test May Predict 20-Year Prostate Cancer Risk:

Image
Single Midlife PSA Test May Identity Long-Term Prostate Cancer Risk | MedPage Today New Evidence Supports Risk-Stratified Screening BLUF (Bottom Line Up Front): A major German study published February 3, 2026, found that men with a PSA below 1.0 ng/mL at midlife face very low prostate cancer risk for the next 20 years—just 3.3% cumulative incidence—suggesting these men could safely reduce screening frequency and avoid unnecessary biopsies. Combined with 23-year follow-up data from Europe's largest screening trial showing a 13% mortality reduction, new FDA-approved blood tests, and updated guidelines for high-risk populations including Black men, the evidence increasingly supports personalized, risk-based screening strategies that maximize early detection benefits while minimizing overdiagnosis harms. A Breakthrough in Risk Stratification For decades, prostate cancer screening has been caught in a dilemma: PSA testing saves lives by detecting cancer early, but it also leads to...
Post a Comment
Read more

Revolutionary Approach: Skipping Biopsy after PSMA PET/CT for Prostate Cancer Surgery Shows Promise

Image
Radical prostatectomy without prior biopsy: an initial decision-making algorithm based on PSMA PET/mpMRI | Prostate Cancer and Prostatic Diseases BLUF (Bottom Line Up Front) Chinese researchers have successfully performed prostate cancer surgery on 120 men without prior biopsy, using advanced imaging alone to diagnose cancer. Published January 31, 2026, in Prostate Cancer and Prostatic Diseases , this study achieved 100% accuracy in detecting clinically significant cancer using a careful algorithm combining PSMA PET/CT and multiparametric MRI scans. While this radical departure from standard practice shows promise for carefully selected patients, it remains experimental and requires independent validation before becoming routine care. The Traditional Path—And Its Problems For decades, prostate biopsy has been the gold standard for diagnosing prostate cancer. A urologist inserts a needle through the rectal wall 10-12 times to collect tissue samples, guided by ultrasound. The procedu...
Post a Comment
Read more

Reprogramming Aggressive Prostate Cancer to Enable Immune mediated Tumor Elimination

Image
Reprogramming Aggressive Prostate Cancer to Enable Immune mediated Tumor Elimination - Paul Mathew - YouTube Breaking the Cold Tumor Barrier: New Bispecific Antibody Targets Hidden Enemy in Prostate Cancer BLUF (Bottom Line Up Front): Researchers at Tufts Medical Center have developed a novel bispecific antibody that could transform prostate cancer treatment by targeting aggressive "basal-type" cancer cells that evade the immune system, resist hormone therapy, and drive bone metastases. By simultaneously blocking two integrin proteins (alpha-5 and alpha-V), the antibody disrupts the mechanical signaling that allows cancer cells to hide from immune surveillance, potentially making prostate cancer responsive to immunotherapy for the first time. The treatment is being prepared for first-in-human clinical trials within the next year through spinout company Jolian Therapeutics. The Hidden Architecture of Aggressive Prostate Cancer For over two decades, Dr. Paul Mathew at Tufts...
Post a Comment
Read more

The Final Journey:

Image
End-Stage Prostate Cancer and End-of-Life Care BLUF (Bottom Line Up Front) Modern palliative and hospice care has transformed the end-of-life experience for men with advanced prostate cancer, making severe suffering largely preventable through proper symptom management. While pain and complications can occur, comprehensive medical support—including pain control, bone-strengthening treatments, radiation for metastases, and psychosocial care—can maintain quality of life and dignity. Medical Aid in Dying (MAiD) is now legal in 10 states plus DC for terminally ill patients, providing an option for those who meet strict criteria. The critical factor is early engagement with palliative care teams, not waiting until the final days. Most men who receive proper end-of-life care can avoid the suffering that drives fears of uncontrolled pain or desperate measures. Introduction: Facing the Unspoken Fear When John Wayne portrayed aging gunfighter J.B. Books in his final film The Shootist (197...
Post a Comment
Read more